Product Information
GS OMEPRAZOLE DR 20 MG ODT is a generic product labeled by L. Perrigo Company, priced at $0.4682 per EA under NDC 00113052074. Its NADAC has been published 324 times since Jul 22, 2020.
FDA first approved this application on Jul 5, 2017.
Strength
20 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113052074
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA209400FDA Approved
7/5/2017
On Market Since
6/19/2018
Pharmacological Classes
Price Statistics
The NADAC for GS OMEPRAZOLE DR 20 MG ODT has been published 324 times since Jul 22, 2020, and over the history we have for it it has risen 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4682 per EA |
|---|---|
| All-time high | $0.5117 (Mar 13, 2024) |
| All-time low | $0.3603 (Nov 22, 2023) |
| 52-week high | $0.4785 |
| 52-week low | $0.4242 |
| Median price | $0.4322 |
| Average price | $0.4252 |
| Largest weekly change | +29.7% (Jun 22, 2022) |
| Weeks tracked | 324 |
| Tracking since | Jul 22, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS OMEPRAZOLE DR 20 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for GS OMEPRAZOLE DR 20 MG ODT, manufactured by L. Perrigo Company, is $0.4682 per EA (NDC 00113052074), effective Sep 30, 2026.
How has the price of GS OMEPRAZOLE DR 20 MG ODT changed over time?
Over the history we have for it, the NADAC for GS OMEPRAZOLE DR 20 MG ODT has risen 26.2%. It has been tracked across 324 weekly CMS publications since Jul 22, 2020.
What are the highest and lowest recorded NADAC prices for GS OMEPRAZOLE DR 20 MG ODT?
Since Jul 22, 2020, the NADAC for GS OMEPRAZOLE DR 20 MG ODT has ranged from a low of $0.3603 (Nov 22, 2023) to a high of $0.5117 (Mar 13, 2024), with a median of $0.4322 per EA.
Are there cheaper alternatives to GS OMEPRAZOLE DR 20 MG ODT?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS OMEPRAZOLE DR 20 MG ODT in a comparable dosage form, but none are currently priced below it.
Who manufactures GS OMEPRAZOLE DR 20 MG ODT?
GS OMEPRAZOLE DR 20 MG ODT (NDC 00113052074) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.